Boston Dynamics, Hyundai Motor Group’s humanoid robot subsidiary, is unlikely to pursue an initial public offering in 2027, a senior Hyundai executive with direct knowledge of the matter told Reuters. The executive cited two conditions not yet met: Atlas robots have not been deployed at scale, and the company remains unprofitable. “It won’t be easy,” the executive said when asked whether an IPO was possible next year. “We need to see conditions and situations,” the person added, asking not to be named because the matter is confidential.
Hyundai Motor Group has not publicly disclosed a timetable or valuation target for a potential Boston Dynamics listing. Analyst estimates cited by Reuters suggest a public debut is more likely in 2029 or 2030.
The Gap Between Ambition and Commercial Reality
Hyundai has stated its target of building a factory capable of producing 30,000 Atlas robots annually by 2028, with initial deployments at its U.S. plant in Georgia that year before expanding across its manufacturing network. Analysts have described those targets as ambitious. Boston Dynamics’ own Spartanburg deployment with BMW – the most commercially significant Atlas deployment disclosed publicly – produced a detailed ten-month operational record with Figure 02, with Figure 03 now beginning logistics sequencing tasks. But large-scale Atlas deployment across multiple customer sites and production environments remains ahead, not behind.
“I think it might take far more time for humanoid robots to replace human workers at the assembly line,” said Kim Hyun-su, a senior fund manager at IBK Asset Management in Seoul. “It’s not difficult to make robots dancing, but it’s challenging to make them carry heavy loads and get involved in manufacturing at plants.”
The IPO Landscape Context
The Boston Dynamics disclosure arrives as the humanoid robot IPO wave accelerates primarily in China. Unitree Robotics completed China’s first domestic A-share humanoid listing in August at a 60.99 billion yuan valuation, with 5,500-times retail oversubscription. AgiBot is pursuing a Hong Kong IPO at a reported $20 billion valuation. LimX Dynamics and Robotera are both in Hong Kong listing discussions. Agility Robotics is advancing toward a U.S. public debut through its SPAC merger with Churchill Capital at a $2.5 billion valuation.
Boston Dynamics’ situation is structurally different from these Chinese listings. Agility Robotics, the closest Western peer by deployment stage, has more than $300 million in booked multi-year revenue from customers including Amazon, GXO, and Toyota. Boston Dynamics has Hyundai as its primary strategic deployment partner and the BMW Spartanburg deployment as its most public commercial reference – a foundation for scale, but not yet evidence of the multi-customer commercial traction that supports a credible public market story.
Investor enthusiasm for Hyundai’s robotics ambitions has been real – Hyundai Motor shares reached record highs earlier in 2026 partly on that thesis. Whether that enthusiasm sustains through a multi-year wait for profitability and scaled deployment will be one of the defining tests of the humanoid robot investment narrative as it moves from private market optimism to public market accountability.
Disclaimer: RobotsBeat is an independent media brand owned and operated by NuvexMedia LLC, publishing news, research, and insights on artificial intelligence, emerging technologies, automation, and related industries. NuvexMedia LLC invests in and collaborates with companies across the AI, Robotics, technology, software, and digital innovation sectors. These relationships do not influence RobotsBeat's editorial coverage, and the publication maintains full editorial independence to provide accurate, timely, and objective information. © 2026 NuvexMedia LLC. All rights reserved. This content is for informational purposes only and should not be considered legal, tax, investment, financial, or other professional advice.
